Collins Cooper C. has filed 5 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 8500 shares of TherapeuticsMD, Inc. ($TXMD) on November 03, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 3, 2025 | TherapeuticsMD, Inc. | $TXMD | Collins Cooper C. | Not found | A | Restricted Stock Units | 8500 | $0.00 | 8,500.0000 | 11,574,000 | 9999.99% | 0.07% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Collins Cooper C. | Not found | M | Common Stock | 8500 | $0.00 | 60,516.0000 | 11,532 | 16.34% | 73.71% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Collins Cooper C. | Not found | M | Restricted Stock Units | 8500 | $0.00 | 0.0000 | 11,532 | 100.00% | 73.71% |
| Aug. 22, 2024 | TherapeuticsMD, Inc. | $TXMD | Collins Cooper C. | Not found | P | Common Stock | 4094 | $1.73 | 52,016.0000 | 11,532,000 | 8.54% | 0.04% |
| Aug. 21, 2024 | TherapeuticsMD, Inc. | $TXMD | Collins Cooper C. | Not found | P | Common Stock | 1200 | $1.70 | 47,922.0000 | 11,532,000 | 2.57% | 0.01% |